01—Abstract
Summary
Summary of the 8-K filed August 26, 2024. Cited figures are marked; the original filing is the authoritative source.
Johnson & Johnson (NYSE: JNJ) disclosed in an 8-K filed August 26, 2024 that Executive Vice President and Chief Human Resources Officer Peter M.
Fasolo will retire. He steps down from the CHRO role and the Executive Committee effective October 1, 2024, and departs the Company at the end of 2024. He has served as CHRO and an Executive Committee member since 2010 and has been with the company since 2004, spanning roughly 16 years of leadership in the role.
The Company has named Kristen Mulholland as his successor, effective October 1, 2024. She also joins the Executive Committee on that date. Ms. Mulholland has been with J&J since 2005 and most recently led Global Total Rewards and Enterprise HR Functions, where she worked with the Board's Compensation & Benefits Committee and played a key role in the separation of the consumer business that formed Kenvue.
Fasolo and Mulholland will overlap in a transition period through year-end. For investors, this is a planned, orderly leadership succession rather than a signal of operational or financial concern.
The filing contains no financial results, guidance, or material financial information. The most relevant takeaways are continuity in talent strategy, with an internal successor who has deep Credo-based and company-specific experience, and a transition window that reduces execution risk.
02—Key points
Key Highlights
- Peter M. Fasolo, EVP and Chief Human Resources Officer, will retire; he steps down from the CHRO role and Executive Committee effective October 1, 2024, and leaves the Company at year-end 2024.
- Kristen Mulholland, a J&J veteran since 2005, is named CHRO and joins the Executive Committee effective October 1, 2024.
- Fasolo served 16 years as CHRO (since 2010) and joined J&J in 2004, overseeing talent strategy through the pandemic and the Kenvue consumer health separation.
- Mulholland's background includes Innovative Medicine and MedTech HR, corporate functions, and most recently Global Total Rewards and Enterprise HR Functions.
- A transition period between Fasolo and Mulholland runs through the end of 2024, supporting continuity.
- The 8-K involves no financial results, guidance, or financial impact; it is a personnel announcement under Item 5.02.
- CEO Joaquin Duato praised the succession as ensuring the human capital strategy remains positioned for future talent and culture needs.
03—Questions
Frequently Asked Questions
Why is Peter Fasolo leaving?
The filing states that Fasolo elected to retire after 16 years as CHRO and a total of about 20 years with the company. No other reason is disclosed.
Who is replacing Peter Fasolo?
Kristen Mulholland, an internal leader who has been with J&J since 2005, will become EVP and Chief Human Resources Officer and join the Executive Committee effective October 1, 2024.
Does this leadership change affect J&J's financial outlook?
The 8-K contains no financial results, guidance, or financial impact disclosures. The change is a planned executive succession, and the filing presents it as a continuity-focused transition with an overlap period through year-end 2024.
Is this an unexpected departure?
No. The announcement describes a retirement with a defined handover period, and Fasolo will remain at the Company through the end of 2024, which suggests a planned transition rather than an abrupt exit.
04—Continue